Literature DB >> 14647510

Inhibition of platelet thromboxane receptor function by a thrombin receptor-targeted pepducin.

Jan Julius Stampfuss, Karsten Schrör, Artur-Aron Weber.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14647510     DOI： 10.1038/nm1203-1447a

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  8 in total

1.  Structural analogues of smoothened intracellular loops as potent inhibitors of Hedgehog pathway and cancer cell growth.

Authors:  Jarrett R Remsberg; Hong Lou; Sergey G Tarasov; Michael Dean; Nadya I Tarasova
Journal:  J Med Chem       Date:  2007-08-08       Impact factor: 7.446

2.  β-arrestin-biased signaling through the β2-adrenergic receptor promotes cardiomyocyte contraction.

Authors:  Richard Carr; Justin Schilling; Jianliang Song; Rhonda L Carter; Yang Du; Sungsoo M Yoo; Christopher J Traynham; Walter J Koch; Joseph Y Cheung; Douglas G Tilley; Jeffrey L Benovic
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-27       Impact factor: 11.205

3.  Interdicting Gq Activation in Airway Disease by Receptor-Dependent and Receptor-Independent Mechanisms.

Authors:  Richard Carr; Cynthia Koziol-White; Jie Zhang; Hong Lam; Steven S An; Gregory G Tall; Reynold A Panettieri; Jeffrey L Benovic
Journal:  Mol Pharmacol       Date:  2015-10-13       Impact factor: 4.436

4.  Protease-activated receptor 4 protects mice from Coxsackievirus B3 and H1N1 influenza A virus infection.

Authors:  Kohei Tatsumi; Clare M Schmedes; E Reaves Houston; Emily Butler; Nigel Mackman; Silvio Antoniak
Journal:  Cell Immunol       Date:  2019-07-03       Impact factor: 4.868

Review 5.  Protease-activated receptor 4: from structure to function and back again.

Authors:  Shauna L French; Justin R Hamilton
Journal:  Br J Pharmacol       Date:  2016-03-10       Impact factor: 8.739

6.  PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation.

Authors:  Simon J Wilson; Fraz A Ismat; Zhaoqing Wang; Michael Cerra; Hafid Narayan; Jennifer Raftis; Timothy J Gray; Shea Connell; Samira Garonzik; Xuewen Ma; Jing Yang; David E Newby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-12-21       Impact factor: 8.311

Review 7.  Protease-Activated Receptor 4 (PAR4): A Promising Target for Antiplatelet Therapy.

Authors:  Gamariel Rwibasira Rudinga; Ghulam Jilany Khan; Yi Kong
Journal:  Int J Mol Sci       Date:  2018-02-14       Impact factor: 5.923

Review 8.  Using PAR4 Inhibition as an Anti-Thrombotic Approach: Why, How, and When?

Authors:  Simeng Li; Volga Tarlac; Justin R Hamilton
Journal:  Int J Mol Sci       Date:  2019-11-11       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.